EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 43 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $11,000 | -15.4% | 1,626 | +87.3% | 0.00% | 0.0% |
| Q4 2019 | $13,000 | +116.7% | 868 | +43.2% | 0.00% | – |
| Q3 2019 | $6,000 | 0.0% | 606 | 0.0% | 0.00% | – |
| Q2 2019 | $6,000 | -25.0% | 606 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $8,000 | -11.1% | 606 | -33.4% | 0.00% | 0.0% |
| Q4 2018 | $9,000 | -18.2% | 910 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $11,000 | -99.6% | 910 | +346.1% | 0.00% | – |
| Q2 2018 | $2,489,000 | +49680.0% | 204 | -57.4% | 0.00% | – |
| Q1 2018 | $5,000 | -28.6% | 479 | -7.0% | 0.00% | -100.0% |
| Q4 2017 | $7,000 | 0.0% | 515 | -23.9% | 0.00% | 0.0% |
| Q3 2017 | $7,000 | +75.0% | 677 | +44.0% | 0.00% | – |
| Q2 2017 | $4,000 | -20.0% | 470 | 0.0% | 0.00% | – |
| Q1 2017 | $5,000 | -28.6% | 470 | -17.3% | 0.00% | -100.0% |
| Q4 2016 | $7,000 | – | 568 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Simplify Asset Management Inc. | 2,700,000 | $823,500 | 0.09% |
| 683 Capital Management, LLC | 2,650,000 | $808,250 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 355,867 | $109 | 0.01% |
| RBF Capital, LLC | 391,265 | $119,336 | 0.01% |
| UBS OCONNOR LLC | 393,975 | $120,162 | 0.00% |
| XTX Topco Ltd | 15,597 | $4,757 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 106,700 | $32,544 | 0.00% |
| AMERIPRISE FINANCIAL INC | 8,592,471 | $2,620,704 | 0.00% |
| DRW Securities, LLC | 120,365 | $37 | 0.00% |
| DFPG INVESTMENTS, LLC | 32,430 | $10,896 | 0.00% |